HD-OPM Archive
Topics › Statins

Statin absolute risk reductions of 1-5% over 5 years are large against lifetime risk

Louis Nervegna · Jun 24, 2024 · ♥ 14 reactions · 5 comments · original Facebook post
StatinsHow to read researchMyths, misinformation & controversies
AI summary & key facts

Reposting an explainer on relative versus absolute risk: statin trials show absolute risk reductions of 1.1% to 4.7% over about 5 years, which the poster argues is substantial against a roughly 20% lifetime heart attack risk. Over decades he suggests lifetime risk could fall toward 10%, an extrapolation.

Reposting this for new members.

Don’t let charlatans and fools lie to you about this on social media.

↪ A 1.1-4.7% absolute risk reduction from statins is large against a 20% lifetime risk

Relative risk vs Absolute risk, when it comes to statin trials.

——

Statins have been shown to reduce absolute risk of having a heart attack or stroke by anywhere from 1.1% to 4.7% in randomized controlled trials lasting about 5 years.

A common claim on social media is that this makes little practical difference.

Let’s examine the basic math behind this claim:

For the average American, the absolute risk of having a heart attack in their entire lifetime is only about 20%. (1 in 5 Americans will have a heart attack in their lifetime.)

A drop in absolute risk of 1.1% to 4.7% in only 5 years reduces this lifetime risk from 20% down to 15.3% to 18.9%. All in just 5 years.

That is huge. If the average American continues this for decades, they will likely drop their lifetime risk of a heart attack or stroke all the way down to 10%.

So instead of 1 in 5 Americans having a heart attack, it would be 1 in 10. That is fantastic. Millions of lives would be saved.

↪ LDL down 39 mg/dL: 20%+ fewer heart attacks in RCTs, 30%+ in cohorts, 50%+ genetically

#absoluterisk#heartattack#statins#stroke
← newer: Ornish trial: lifestyle program cut cardiac events, but planolder: Mendelian randomization finds no causal effect of VO2-max on →